Advertisement
TwistDx Limited
TwistDx Limited

The Scientist

» generics and disease/medicine

Most Recent

Contributors

April 1, 2012

Meet some of the people featured in the April 2012 issue of The Scientist.

0 Comments

image: Antibiotics in the Animals We Eat

Antibiotics in the Animals We Eat

By | April 1, 2012

Low-dose antibiotics in animal feed fuel drug-resistance in human infectious diseases.

0 Comments

image: Are Cancer Stem Cells Ready for Prime Time?

Are Cancer Stem Cells Ready for Prime Time?

By | April 1, 2012

A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.

48 Comments

image: Deliberating Over Danger

Deliberating Over Danger

By | April 1, 2012

The creation of H5N1 bird flu strains that are transmissible between mammals has thrown the scientific community into a heated debate about whether such research should be allowed and how it should be regulated.

16 Comments

image: Speaking of Science

Speaking of Science

By | April 1, 2012

April 2012's selection of notable quotes

2 Comments

image: Failed Drugs Expose Preclinical Blunders

Failed Drugs Expose Preclinical Blunders

By | March 30, 2012

Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.

2 Comments

image: Courts Re-Examining Gene Patents

Courts Re-Examining Gene Patents

By | March 28, 2012

The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.

2 Comments

image: Mouse Made For You

Mouse Made For You

By | March 23, 2012

Mice “avatars” grafted with patient tumor tissue help identify effective drug regimens.

4 Comments

image: Upheaval Over Children’s Health Study

Upheaval Over Children’s Health Study

By | March 21, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

0 Comments

image: Prometheus Patents Overturned

Prometheus Patents Overturned

By | March 20, 2012

The US Supreme Court ruled that two dose calibration methods from biotech company Prometheus Laboratories cannot be patented.

12 Comments

Advertisement
EMD Millipore
EMD Millipore

Popular Now

  1. Neanderthal-Human Hybrid Unearthed
  2. Extra DNA Base Discovered
    The Nutshell Extra DNA Base Discovered

    An epigenetic variant of cytosine is stable in the genomes of living mice, suggesting a possible expansion of the DNA alphabet.

  3. Next Generation: Smart Insulin Patch
  4. LabQuiz: Cell Health
    Sponsored Quiz LabQuiz: Cell Health

    Are you a Cell Doctor? Find out how much you really know about apoptosis, autophagy, oxidative stress, and factors affecting cell health and receive a free wallchart entitled “Apoptosis Signaling and Detection” for taking our LabQuiz.

Advertisement
Advertisement
The Scientist